Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

PURPOSE: Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Brown, Karen T., Do, Richard K., Gonen, Mithat, Covey, Anne M., Getrajdman, George I., Sofocleous, Constantinos T., Jarnagin, William R., D’Angelica, Michael I., Allen, Peter J., Erinjeri, Joseph P., Brody, Lynn A., O’Neill, Gerald P., Johnson, Kristian N., Garcia, Alessandra R., Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B., Schwartz, Lawrence H., DeMatteo, Ronald, Abou-Alfa, Ghassan K.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2016
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966514/
https://ncbi.nlm.nih.gov/pubmed/26834067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.0821
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars